Quantcast

Latest Stem cells Stories

2014-05-12 23:06:20

STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs). Vancouver, British Columbia (PRWEB) May 12, 2014 STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs). When added to...

2014-05-12 16:28:31

Partnership between two preeminent institutions serving the Midwest and Northeast will bring synergies in blood and laboratory services, medical programs, cell therapies and research KANSAS CITY, Mo. and NEW YORK, May 12, 2014 /PRNewswire-USNewswire/ -- Community Blood Center of Greater Kansas City (CBC) and New York Blood Center (NYBC) announced today that they are combining their operations to create one of the leading blood centers serving patients and hospitals in the Northeast...

'Heart Disease-On-A-Chip' Made From Patient Stem Cells
2014-05-12 03:22:55

[ Watch The Video: Cardiac Tissue Contractile Strength Differences Shown Using “Heart-On-A-Chip” ] Harvard University Harvard scientists have merged stem cell and 'organ-on-a-chip' technologies to grow, for the first time, functioning human heart tissue carrying an inherited cardiovascular disease. The research appears to be a big step forward for personalized medicine, as it is working proof that a chunk of tissue containing a patient's specific genetic disorder can be replicated...

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-12 08:33:04

SAN DIEGO, May 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced that the Company's Excellagen(®) flowable dermal matrix in combination with Orbsen Therapeutics' mesenchymal stromal stem cell therapy Cyndacel-M(TM) has been selected for clinical evaluation in a Phase 1b safety study for the potential treatment of chronic diabetic wounds to be funded by the European Union under EU Framework 7 (FP7). The project, known by the...

2014-05-12 08:32:37

DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sqctb8/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The...

2014-05-09 23:09:06

Tom McManus, former professional football player with Jacksonville Jaguars, is teaming up with SmartChoice® Stem Cell Institute as a spokesperson to promote awareness of benefits and success of Adult Stem Cell procedures as non-surgical treatment for sports injuries, arthritis, joint and back pain. Jacksonville, FL (PRWEB) May 09, 2014 Tom McManus, former professional football player with the Jacksonville Jaguars is teaming up with SmartChoice® Stem Cell Institute as a...

2014-05-09 16:24:29

New Technique Expands Number of Functional Cord Blood Stem Cells for Transplantation NEW YORK, May 9, 2014 /PRNewswire-USNewswire/ -- Adults suffering from diseases such as leukemia, lymphoma, and other blood-related disorders may benefit from life-saving treatment commonly used in pediatric patients. Researchers at the Icahn School of Medicine at Mount Sinai have identified a new technique that causes cord blood (CB) stems cells to generate in greater numbers making them more useful...

2014-05-08 23:12:18

Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute are granted U.S. Patent No. 8,716,017 entitled, “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells.” San Diego, CA (PRWEB) May 08, 2014 Xcelthera Inc, a major innovator in the stem cell research market and one of the first U.S. companies formed for clinical applications of human embryonic stem cell (human ES cell)...

2014-05-08 23:08:30

This is an important step forward in better assessing the cardiac safety of new drug compounds Cleveland, Ohio (PRWEB) May 08, 2014 ChanTest announces a new “Heart-in-a-Dish” in vitro cardiac safety assessment tool to support this critical component of the drug development process for biopharmaceutical companies. ChanTest has developed this breakthrough in safety assessment by taking advantage of the pairing of two recent technologies – stem cell-derived human cardiomyocytes, and...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related